about
Pharmacological interventions for people with borderline personality disorderChlorpromazine versus reserpine for schizophreniaChlorpromazine versus reserpine for schizophreniaSupportive therapy for schizophreniaCrisis intervention for people with severe mental illnessesElectroconvulsive therapy for treatment-resistant schizophreniaAcupuncture for schizophreniaAnticholinergics for neuroleptic-induced parkinsonism and tardive dyskinesiaTrifluoperazine versus placebo for schizophreniaCrisis intervention for people with severe mental illnessesInformation and communication technology in patient education and support for people with schizophreniaFamily intervention (brief) for schizophreniaHaloperidol for long-term aggression in psychosisHaloperidol dose for the acute phase of schizophreniaBrief family intervention for schizophreniaFlupenthixol versus placebo for schizophreniaIntermittent drug techniques for schizophreniaTrifluoperazine versus placebo for schizophreniaChlorpromazine versus placebo for schizophreniaFirst-rank symptoms for schizophreniaOlanzapine discontinuation for schizophreniaVirtual reality for treatment compliance for people with serious mental illnessHaloperidol versus placebo for schizophreniaInformation and communication technology based prompting for treatment compliance for people with serious mental illnessBromperidol decanoate (depot) for schizophreniaFlupenthixol versus placebo for schizophreniaHaloperidol for psychosis-induced aggression or agitation (rapid tranquillisation)Bromperidol decanoate (depot) for schizophreniaAntipsychotic combinations for schizophreniaRisperidone for psychosis induced aggression or agitationChlorpromazine for psychosis induced aggression or agitationHaloperidol (rapid tranquilisation) for psychosis induced aggression or agitationChlorpromazine for psychosis induced aggression or agitationRehabilitation programmes for schizophreniaDepot fluspirilene for schizophreniaHaloperidol versus placebo for schizophreniaCrisis intervention for people with severe mental illnessesSupportive therapy for schizophreniaElectroconvulsive therapy for schizophreniaChlorpromazine versus placebo for schizophrenia
P50
Q22252974-DA4EF7EC-4CCE-4F25-B038-AE5102EB24F1Q24185855-920803DD-D10B-4843-A0F3-AA7E4E8760CCQ24186067-91B4BE23-B0A8-44D7-A4DF-F1D20E8E9DDCQ24186517-892A5BE4-2B5C-4ADC-81A5-0BD1E0D886BCQ24187228-C9B809A9-063E-468C-81FB-D54B215B6B0EQ24187594-E46F277C-537E-4604-B257-F4CC40B13629Q24193093-2F8364BC-966C-4D09-B4F6-482D6AA1F3F3Q24193307-6DD34FE1-0ACF-44AF-A73A-D4AAB4ADCED4Q24197679-BBBAA48B-4474-426C-B406-886E84771256Q24198018-FB553FE5-41F1-4D03-B0ED-09C39E5A4B33Q24198042-94EE661B-1F4E-4A68-9B64-846AD7CB6239Q24198051-6CD94F2B-E61A-4B67-A626-AF28A882E8F4Q24198874-CE6158A9-2986-404B-AB67-A83564385908Q24200200-B9A0C8E0-C2DE-4C80-8FD6-692F497AE204Q24200537-707DCD13-51C0-4964-9385-E77B196C4723Q24200708-2DEBD944-62BD-44D1-A677-09B8483015C2Q24201124-22FC11E0-B0ED-4AFE-827D-67538ECCA808Q24201149-87A6401E-DCA5-4D37-927F-5A3E26C25980Q24201214-DCC22D93-2C41-4C07-A0CB-0777DB7CF1C1Q24201433-01A138B5-52B1-4910-84CA-147727215A67Q24201521-5EAED74F-4A88-4724-8E3B-CDF546670244Q24202426-871B9142-C87E-4F1C-8B53-031E4762BD52Q24202457-367FE757-1E7F-4FDD-9395-CC65C1FC1FC4Q24202535-2C6489B6-AEEA-4742-B2C4-86CFA2D7F7E4Q24202780-8F76B62E-BCC1-4494-9079-2940E13A74CAQ24202853-3A93C9D6-70C1-45A4-8788-22849B25506EQ24203034-210FF0B6-768F-4943-AD6A-8A3B32A64C47Q24234287-8BAA2536-5BBA-4A18-9C33-153A5A755684Q24234513-17040577-6E30-4736-980F-EC7E39417053Q24235440-BFBC0117-2FBE-4E99-897D-886D6800723FQ24235748-DC6B61FA-84DC-4025-A921-FC33084CA891Q24236734-42963764-F2E3-4BE1-AA9B-0400CD2A47E3Q24241702-D8D0ED42-A592-49B4-8B17-F0EE53AB6EEBQ24242679-8714CCF2-78EF-49E1-9F91-2E4041591CDBQ24243132-4CF7A5C1-1C8A-4EBD-A153-3CEA454CB696Q24243823-998DF3F9-DBEA-482B-9177-13EF97FCF499Q24243903-769E0403-722F-4055-8C64-66B413F368B9Q24244072-A85AEE6D-BA1B-4C64-AEA0-281B4858D7DBQ24244285-BED8FD2D-A192-462F-9701-69CC80511092Q24245181-7CDB49FF-00BB-4BC2-9042-C4EEEB49A38D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Clive E Adams
@ast
Clive E Adams
@en
Clive E Adams
@es
Clive E Adams
@nl
type
label
Clive E Adams
@ast
Clive E Adams
@en
Clive E Adams
@es
Clive E Adams
@nl
altLabel
Adams CE
@en
prefLabel
Clive E Adams
@ast
Clive E Adams
@en
Clive E Adams
@es
Clive E Adams
@nl
P106
P31
P4012
P496
0000-0003-1628-4020